Vivos Therapeutics (VVOS) Other Working Capital Changes (2020 - 2026)
Vivos Therapeutics (VVOS) reported Other Working Capital Changes of $18000.0 for Q1 2026, up 104.51% year-over-year from $8801.5 in Q1 2025, and down 93.64% quarter-over-quarter from $283000.0 in Q4 2025.
Vivos Therapeutics (VVOS) Other Working Capital Changes (2020 - 2026) Analysis & Trends
Vivos Therapeutics (VVOS) has 7 years of Other Working Capital Changes data on file, last reported at $18000.0 in Q1 2026.
- Other Working Capital Changes for Q1 2026 came in at $18000.0, up 104.51% year-over-year; the trailing twelve-month figure through Mar 2026 was $472000.0 (up 164.13% YoY), and the FY2025 annual result was $55000.0, down 67.07% from the prior year.
- Other Working Capital Changes eased to $18000.0 in Q1 2026 per VVOS's latest filing, from $283000.0 in the prior quarter.
- Over five years, Other Working Capital Changes peaked at $1.1 million in Q4 2024 and troughed at -$784000.0 in Q2 2024.
- A 5-year average of -$42235.3 and a median of -$130000.0 in 2025 frame the typical range for Other Working Capital Changes.
- On a YoY basis, Other Working Capital Changes climbed as much as 460.0% in 2024 and fell as far as 1236.73% in 2024.
- A 5-year view of Other Working Capital Changes shows it stood at -$667000.0 in 2022, then surged by 38.83% to -$408000.0 in 2023, then jumped by 370.1% to $1.1 million in 2024, then tumbled by 74.32% to $283000.0 in 2025, then sank by 93.64% to $18000.0 in 2026.
- Business Quant data shows VVOS's Other Working Capital Changes at $18000.0 in Q1 2026, $283000.0 in Q4 2025, and -$130000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn |
| 10 | Vivos Therapeutics | 7.39 Mn | 5.16 Mn | 3.06 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 18,000.00 |
| Mar 31, 2026 | 18,000.00 |
| Dec 31, 2025 | 283,000.00 |
| Dec 31, 2025 | 283,000.00 |
| Sep 30, 2025 | -130,000.00 |
| Sep 30, 2025 | -130,000.00 |
| Jun 30, 2025 | 301,000.00 |
| Jun 30, 2025 | 301,000.00 |
| Mar 31, 2025 | -399,000.00 |
| Mar 31, 2025 | -399,000.00 |
| Dec 31, 2024 | 1.10 Mn |
| Dec 31, 2024 | 1.10 Mn |
| Sep 30, 2024 | -655,000.00 |
| Sep 30, 2024 | -655,000.00 |
| Jun 30, 2024 | -784,000.00 |
| Jun 30, 2024 | -784,000.00 |
| Mar 31, 2024 | 504,000.00 |
| Mar 31, 2024 | 504,000.00 |
| Dec 31, 2023 | -408,000.00 |
| Dec 31, 2023 | -408,000.00 |